Lessons Learned from Evaluation of LLM based Multi-agents in Safer Therapy Recommendation
This addresses therapy recommendation challenges for chronic patients with multimorbidity, but results are incremental as single agents matched multi-agent performance without clear superiority.
The study investigated using an LLM-based multi-agent system for safer therapy recommendations for chronic patients with multimorbidity, finding that a single agent performed as well as multi-agent teams, with best models providing correct but incomplete recommendations and some adding unnecessary medications.
Therapy recommendation for chronic patients with multimorbidity is challenging due to risks of treatment conflicts. Existing decision support systems face scalability limitations. Inspired by the way in which general practitioners (GP) manage multimorbidity patients, occasionally convening multidisciplinary team (MDT) collaboration, this study investigated the feasibility and value of using a Large Language Model (LLM)-based multi-agent system (MAS) for safer therapy recommendations. We designed a single agent and a MAS framework simulating MDT decision-making by enabling discussion among LLM agents to resolve medical conflicts. The systems were evaluated on therapy planning tasks for multimorbidity patients using benchmark cases. We compared MAS performance with single-agent approaches and real-world benchmarks. An important contribution of our study is the definition of evaluation metrics that go beyond the technical precision and recall and allow the inspection of clinical goals met and medication burden of the proposed advices to a gold standard benchmark. Our results show that with current LLMs, a single agent GP performs as well as MDTs. The best-scoring models provide correct recommendations that address all clinical goals, yet the advices are incomplete. Some models also present unnecessary medications, resulting in unnecessary conflicts between medication and conditions or drug-drug interactions.